Chemotherapy may be more effective in highly proliferative ovarian carcinomas--a translational research subprotocol of a prospective randomized phase III study (AGO-OVAR 3 protocol)

Gynecol Oncol. 2006 Oct;103(1):67-71. doi: 10.1016/j.ygyno.2006.01.037. Epub 2006 Mar 3.

Abstract

Objective: Proliferative activity (PA) may be an indicator of a neoplasm's malignant potential, and it has been described as a prognostic factor in different malignant tumors. It was our aim to study the prognostic significance of PA defined by Ki-S5 and Ki-S2 immunohistochemical staining in a large homogeneously treated cohort with primary advanced-stage ovarian carcinomas.

Methods: Immunohistochemical detection of PA was performed using monoclonal Ki-S5 and Ki-S2 antibodies and standard immunostaining protocols. Kaplan-Meier survival analysis and Cox regression multivariate analysis were performed.

Results: High Ki-S5 PA was associated with a better prognosis. This finding was statistically significant after univariate and multivariate analysis. A similar trend was found in the subgroup of completely debulked patients. No prognostic effect of Ki-S2 PA could be detected in the present study.

Conclusion: High Ki-S5 PA is an indicator of a more favourable prognosis in patients with advanced ovarian carcinomas. Antiproliferative chemotherapy may be more effective in tumors which are highly proliferative, possibly due to an increased chemosensitivity.

MeSH terms

  • Aged
  • Antibodies, Monoclonal / chemistry
  • Cell Growth Processes / physiology
  • Clinical Trials, Phase II as Topic
  • Cohort Studies
  • Combined Modality Therapy
  • Female
  • Humans
  • Immunohistochemistry
  • Middle Aged
  • Neoplasm Staging
  • Ovarian Neoplasms / drug therapy*
  • Ovarian Neoplasms / pathology*
  • Ovarian Neoplasms / surgery
  • Paraffin Embedding
  • Prognosis
  • Proportional Hazards Models
  • Prospective Studies
  • Randomized Controlled Trials as Topic

Substances

  • Antibodies, Monoclonal